ACHL

ACHL


A Next Generation of Pneumococcal Disease Protection

In this modular video-based activity, multidisciplinary faculty provide their perspectives on the changing epidemiology of pneumococcal disease and the protection afforded by a next generation of conjugate vaccines. Hear expert insights on considerations for next generation pneumococcal vaccine use, patient access to these newer vaccines, and strategies for engaging patients. Two case studies dr...
ACHL

All in for ALL: Mitigating VOD Risk in Patients Being Treated for R/R ALL

Are you involved with mitigating veno-occlusive disease (VOD) risk in patients with relapsed/refractory acute lymphoblastic leukemia (R/R ALL)? Are you current with the latest guidance regarding R/R ALL treatment? The therapeutic landscape for R/R ALL now comprises of a wide variety of agents. Stay abreast of the most recent R/R ALL treatment updates as well as the latest in how to manage VOD ri...
University of Chicago Pritzker School of Medicine

Answering the Call: Nurse-Led Strategies to Improve Compliance with Hemophilia Prophylaxis

Prophylactic management of hemophilia continues to be a challenge. The nurse-led activity discusses treatment strategies, safety and efficacy of current available products, and how to improve patient adherence. In this clinical commentary Kerry H. Hansen, RN, BS and Skye Peltier, MPH, PA-C review best practices to facilitate successful therapeutic interventions with hemophilia A Kerry H. Hanse...
ACHL

Approaches to Acute Iliofemoral Deep Vein Thrombosis: Medical and Endovascular Management

Nearly half of all patients with deep vein thrombosis (DVT) go on to develop post-thrombotic syndrome (PTS). This CME-certified, 30-minute touchpoint features an expert interventional radiologist, Dr. Kush Desai from Northwestern Medicine, and includes video commentary on key clinical trial data and patient selection for endovascular interventions to reduce the risk of PTS. Dr. Desai also addres...
ACHL

Beyond the Procedure: Evolving the Current Standard of Care for Patients with PAD

In three fast-paced modules, a multispecialty panel of cardiology, radiology, and vascular surgery experts provide perspectives on preventing adverse limb events in patients undergoing revascularization. Vascular medicine expert Dr. Anahita Dua moderates these brief discussions and case presentations with a focus on the latest clinical trial data and implications for patient care.
ACHL

Case Challenges in Patients With EGFR-Mutant NSCLC

This activity offers a case challenge of two patients with EGFR-mutant NSCLC, through which learners apply knowledge from the molecular testing guidelines and evidence from clinical trials as presented in the related activity, Identifying Actionable Markers to Guide Therapy for Patients With EGFR-Mutant NSCLC. Learners work through patient cases during which they are questioned about how they wo...
ACHL

Checkpoint Blockade in the Adjuvant and Neoadjuvant Settings: Key Considerations for the Surgical Oncologist

A multidisciplinary panel of faculty discuss the use of neoadjuvant and adjuvant immunotherapy for esophageal and gastric cancers in this recorded virtual tumor board. Throughout the case discussions, faculty discuss how to properly incorporate immunotherapies into care plans based on the latest clinical trial data and recommendations. The faculty also highlight the role of biomarkers in identif...
Society of Surgical Oncology (SSO)

Community Conversations: Real-World Strategies for Overcoming Disparities in Immunotherapy Cancer Care

These powerful and captivating stories follow real-world patients on their immunotherapy journeys. Multidisciplinary cancer care clinicians also provide insightful perspectives on these stories. Experts review the latest data and guidance to frame ongoing disparities with immunotherapy access and share strategies to overcome barriers and broaden therapeutic opportunities for underserved patien...
ACHL

Complex Chronic Deep Venous Disease: A Multidisciplinary Discussion

Are you confident with managing cases of complex chronic deep venous disease? This 30-minute roundtable discussion, features leading venous disease experts, Minhaj Khaja, MD, MBA, FSIR from University of Virginia; Andrea Obi, MD from University of Michigan; and Aditya Sharma, MD, from University of Virginia who highlight complex cases related to chronic deep venous disease. Faculty discuss the l...
ACHL

Considerations for Antimicrobial Selection in Clostridioides difficile Infection

This educational program is designed for infectious disease pharmacists interested in new therapies and clinical trials in the treatment of CDI. Dr. Paul Feuerstadt and Dr. Kevin Garey discuss community and healthcare-associated infections, recent updates to guidelines, and evidence-based selection of antimicrobial therapy for the treatment of initial infection and prevention of recurrence. W...
ACHL

Diagnostic Pathways for Alzheimer Disease: Optimizing Multidisciplinary Practices

Alzheimer disease (AD) is associated with a significant and increasing burden for patients, their caregivers, and society as the population ages. This activity has been designed with differing educational pathways for specialists and nonspecialists to address the needs of their clinical practices, and will help clinicians identify and differentiate AD from normal aging and other neurocognitive d...
ACHL

Differentiating Early Signs of Alzheimer Disease From Normal Signs of Aging and Determining Best Next Steps.

Join us for this in-depth look at the early diagnosis of Alzheimer disease. Dr. James Galvin presents ways to differentiate Alzheimer disease from other neurodegenerative disorders, implement appropriate testing methods for earlier detection, and apply recent evidence to treatment selection to optimize patient outcomes.
ACHL

Highlights from Kidney Week

Expert faculty, Dr. Jai Radhakrishnan explores clinical trial data coming out of ASN 2021, and provides learners with up-to-date knowledge on focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN). This brief interview-style video offers insights into the patient burden of chronic kidney disease, advances in understanding the pathophysiology, and emerging approaches to treatment fo...
ACHL

Highlights in FSGS and IgAN

Dr. Jai Radhakrishnan explores data on focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) from a recent nephrology meeting in this brief interview-style video. Dr. Radhakrishnan discusses emerging data on the pathophysiology and treatment of FSGS and IgAN in addition to the clinical implications of these advances. Focal segmental glomerulosclerosis and IgAN are glomerular di...
ACHL

Hot Topics in PAH: What We’ve Learned in the Past Year

How can clinicians improve early detection of PAH? What are some practical strategies for managing PAH patients in today’s world? What recent data support current treatment strategies, and what are emerging therapeutic options? This 30-minute multimedia Q&A touchpoint “Hot Topics” CME activity features leading pulmonology expert Dan Schuller, MD, from Texas Tech University Health Sciences ...
ACHL

Identifying Actionable Markers to Guide Therapy for Patients With EGFR-Mutant NSCLC

This interactive digital activity combines animated slides and expert video commentary on molecular testing recommendations, guidance on interpreting molecular testing results, and clinical trial evidence to enhance the implementation of precision medicine in the care of patients with EGFR-mutant NSCLC. Through this education, learners explore best practices for EGFR mutation testing, applicatio...
ACHL

Improving the Prognosis for Patients with BRAF-Mutant and/or MSI-H mCRC

Are you current with the latest updates with MSI-H/dMMR and/or BRAF-mutant metastatic colorectal cancer? In this case-based activity, leading expert and researcher, Dr. Dung Le discusses the latest approvals and recommendations for patients with MSI-H/dMMR and/or BRAF-mutant mCRC. This activity also features interactive case presentations which involve biomarker testing, treatment selection, and...
ACHL

Individualizing Prostate Cancer Treatment: Special Considerations for Gay and Bisexual Men

This activity features a panel consisting of an oncologist and leading experts (a urologist and a researcher) in prostate cancer care considerations in gay and bisexual men (GBM), where they discuss quality of life considerations and disparities. The panel’s aim is to provide clinicians with real-world strategies to facilitate optimal communication and shared decision-making with these patient...
ACHL

Keeping Up the Pace in IBD: Adaptive Learning to Optimize Therapeutic Decision-Making for Patients with UC and CD

Whether you’re a specialist looking for advanced-level learning around optimally managing Crohn’s disease and ulcerative colitis, a generalist needing to expand your knowledge of inflammatory bowel disease (IBD), or an allied healthcare professional wanting to support patients, don’t miss the opportunity to participate in this one-of-a-kind educational experience. In this adaptive learning...
ACHL

Late-breaking Science with DOACs and Implications for Patient Care

Hear from Christian Ruff, MD, MPH on the latest clinical trial data related to DOACs and implications for patient care. This expert perspective provides clinicians with practical insights to apply to their practice. Dr. Ruff discusses the most recent evidence with DOACs across a multitude of disease states, including acute venous thromboembolism in patients with elevated BMI, peripheral artery d...
ACHL

Latest Data in FSGS and IgAN

Expert faculty, Dr. Richard Lafayette, explores clinical trial data coming out of a recent nephrology meeting, and provides learners with up-to-date knowledge on focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN). This brief interview-style video offers insights into the patient burden of chronic kidney disease, advances in understanding the pathophysiology, and emerging approa...
ACHL

Leading the Way: Improving Breast Cancer Disparities for Minority Patients in Chicago Race, Ethnicity, and Breast Cancer: Screening and Diagnosis

This activity was included in a series of workshops as part of a quality improvement program “Leading the Way: Improving Breast Cancer Disparities for Minority Patients in Chicago.” Led by Olufunmilayo Olopade, MD, FACP, this initiative is studying the effectiveness of targeted interventions in improving breast cancer care for African American women treated in Cook County. In this worksho...
University of Chicago Pritzker School of Medicine

Leading the Way: Improving Breast Cancer Disparities for Minority Patients in Chicago Race, Ethnicity, and Breast Cancer: Treatment

This activity was included in a series of workshops as part of a quality improvement program “Leading the Way: Improving Breast Cancer Disparities for Minority Patients in Chicago.” Led by Olufunmilayo Olopade, MD, FACP, this initiative is studying the effectiveness of targeted interventions in improving breast cancer care for African American women treated in Cook County. In this worksho...
University of Chicago Pritzker School of Medicine

LET'S BE BLUNT: Collaborating With Patients With Major Depressive Disorder to Achieve Full Functional Recovery

In this, 60-minute activity, expert faculty review recommendations for the treatment of major depressive disorder (MDD), case vignettes, and “How I Do It” best practices. Discussions focus on the impact of measurement-based care for tracking symptoms of depression; assessment and management of treatment-related emotional blunting; as well as, strategies on how to involve patients in shared d...
ACHL

LET'S BE BLUNT: Collaborating With Patients With Major Depressive Disorder to Achieve Full Functional Recovery (Patient Whiteboard)

LET'S BE BLUNT: Collaborating With Patients With Major Depressive Disorder to Achieve Full Functional Recovery (Patient Whiteboard) is a brief whiteboard animation developed to provide patients with the right information to achieve full functional recovery and find your light again. Learn strategies on: • the signs, symptoms, and causes of emotional blunting • how to recognize when your...
ACHL

Matching Treatment to Mutations: Clinical Pathways to Optimize RET+ Testing in NSCLC and Thyroid Cancer

This recording from a series of expert-led small group meet-ups will increase your knowledge of RET inhibitors, help you gain confidence in utilizing biomarkers to inform treatment decisions, and improve collaboration between oncologists and pathologists to optimize precision medicine for RET-positive metastatic NSCLC and advanced thyroid cancer.
Penn State College of Medicine

Menopause Matters…Let’s Start Paying Attention to Racial and Ethnic Differences.

This activity addresses disparities in the treatment of vasomotor symptoms faced by menopausal women of diverse racial and ethnic backgrounds. Faculty discussion covers overcoming these disparities, guideline recommendations, a novel mechanism for controlling vasomotor symptoms, and strategies to educate patients. First-hand patient testimonials complement the discussion.
ACHL

Multidisciplinary Viewpoints on NTM-LD Diagnosis and Management

In two virtual roundtables, a pulmonologist, infectious disease specialist, and clinical pharmacist share their experiences in addressing challenges in diagnosing and treating patients with NTM-LD. The expert panel discusses strategies for expediting diagnosis and improving patient care and outcomes within the context of a patient’s reflections on the path to diagnosis and their treatment expe...
ACHL

Next Generation Pneumococcal Vaccines: What You Need to Know

What’s new with pneumococcal vaccines? In 2021, two exciting, next-generation pneumococcal vaccines have become available. Expert faculty from Loma Linda University, the University of Pittsburgh School of Medicine, and the Lewis Katz School of Medicine at Temple University recently led a symposium at a major internal medicine meeting outlining the characteristics and latest recommendations wit...
ACHL

Pathways to Transfusion Independence & Reduced Health Complications: Advances for Lower-Risk MDS

In this dynamic case challenge format, expert faculty work through two patient cases and offer supporting data and practical experience to establish optimal recognition, diagnostic, and treatment practices, and discuss opportunities for shared decision making with patients. Learners are questioned about how they would proceed at different clinical decision points, and faculty commentaries offer ...
ACHL

PFF Summit Highlights: News You Can Use

Across three brief videos, expert faculty Dr. Joseph Lasky discusses highlights and data from the PFF Summit 2021, which took place virtually. Dr. Lasky provides insights into updated diagnostic guidance, emerging therapies, and patient perspectives across the spectrum of interstitial lung diseases (ILD). Don’t miss this opportunity to hear the latest research in ILD! A differential diagnos...
ACHL

Practical Considerations for Patients with PAD Post-Revascularization

This vlog provides learners with the perspective of a leading vascular medicine expert, Dr. Anahita Dua, on recent advances and practical considerations for patients with PAD post-revascularization. Talking points include the latest approvals and evidence, real-world implications of these recent advances, and roles of the interdisciplinary team in the management of this patient population. Th...
ACHL

Practical Guidance for the Community Oncologist — Incorporating Advances in Therapy for Metastatic TNBC: A Focus on TROP2

Are you involved in treating patients with triple negative breast cancer (TNBC)? The emergence of TROP2-directed antibody drug conjugate (ADC) technology has paved the way for exciting new targeted treatment approaches for patients with TNBC. What are the latest data with these ADCs? Why is TROP2 an effective target in TNBC? How do we best incorporate these TROP2-targeted ADCs into TNBC care...
Rush University Medical Center

Practical Solutions to Prevent and Prepare for Severe Hypoglycemia

Episodes of hypoglycemia, including those that are severe, still occur despite new pharmacotherapies and the increased use of continuous glucose monitoring. Do you know which of your patients are at risk? Are they prepared with an active glucagon prescription? This activity helps you identify at risk patients and ensure they are prepared with access to glucagon. Included with the education are t...
ACHL

Practical Tools & Expert Guidance for the Nurse Navigator and Clinical Team: Strategies to Reduce Treatment Disparities in Multiple Myeloma

This immersive practice guide offers a “how to” method for introducing day-to-day strategies in the real world through data, guidelines, and decision-making recommendations. Expert faculty address which approaches may not be working, complexities in managing this patient population, insights on how the latest evidence supports a practical recommendation and review available therapies to opti...
ACHL

Precision Medicine for All: Strategies for Meaningful and Sustainable Improvements to Reduce Health Disparities in NSCLC

Despite the advances in precision medicine for non-small cell lung cancer (NSCLC), a significant proportion of patients, particularly African American and Hispanic patients, face inequities with access to these health breakthroughs. In this activity, expert faculty focus on the latest evidence with NSCLC disparities of care and how to best overcome these barriers. The activity also reviews how t...
Rush University Medical Center

Race, Ethnicity, and Breast Cancer: Health Equity Panel Discussion

This activity was included in a series of workshops as part of a quality improvement program “Leading the Way: Improving Breast Cancer Disparities for Minority Patients in Chicago.” Led by Olufunmilayo Olopade, MD, FACP, this initiative is studying the effectiveness of targeted interventions in improving breast cancer care for African American women treated in Cook County. In this panel d...
University of Chicago Pritzker School of Medicine

Real-World Experience in Diagnosing and Managing PNH in Special Patient Populations

In a “how I do it” clinical commentary, Dr. Jamile Shammo and Dr. Ilene Weitz share their real-world experience in the diagnosis and management of PNH in special patient populations. This case-based activity includes clinical scenarios and treatment strategies to improve patient outcomes.
ACHL

Real-World Perspectives on the Role of TYK2 Inhibitors in the Treatment of Psoriasis

How are TYK2 inhibitors different from conventional JAK inhibitors? In what patient population would they be best suited? Find out in this expert-led clinical review and panel discussion that provides the knowledge you need on the investigational TYK2 inhibitors and their potential roles in personalized psoriasis treatment plans. This content is available across two modules, allowing you to cho...
ACHL

Spotlight on IRON CLAD: Clinical Review of IV Iron Replacement Therapy for Cancer-and Chemotherapy-Induced Anemia

This quick, comprehensive video will review the diagnosis and treatment of cancer- and chemotherapy-induced anemia (CIA). Expert faculty, Dr. Jeffrey Gilreath from University of Utah Hospitals and Clinics will discusses the role of intravenous (IV) iron replacement monotherapy, including ferric carboxymaltose (FCM), recent clinical trial data supporting its benefit in treatment of CIA, and mana...
ACHL

T2D Management in Primary Care Practice: Addressing the Weight of it All

This expert-led activity offers a “how to” method for introducing strategies that support management of both dysglycemia and obesity. This activity highlights the ramifications of untreated obesity in patients with dysglycemia to underscore the importance of early obesity intervention. It also outlines ways to individualize obesity and dysglycemia management, recognize the benefits of earlie...
ACHL

Telling the Story of IBD: Helping Patients Understand the Promise of New Therapies

Telling the Story of IBD: Helping Patients Understand the Promise of New Therapies is a resource to help IBD patients: • Communicate with their healthcare team • Engage in treatment decisions • Understand when their therapy may not be optimal • Adopt everyday changes to manage their symptoms Access these resources and stories from patients with IBD to empower patients to take an a...
ACHL

Tryptase Testing in Chronic Mast Cell Disorders and Acute Settings

Are you familiar with the role of serum tryptase testing in diagnosing idiopathic anaphylaxis and mastocytosis? What role does serum tryptase play in the ongoing management of patients who have anaphylactic reactions to insect venom, and are there different considerations when a patient has a known trigger? Expert faculty Dr. Phil Lieberman shares his insights on serum tryptase testing in clinic...
ACHL

Tryptase Testing: Clinical Utility and Application During COVID-19 Vaccination Reactions

What is the risk of anaphylaxis following vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; COVID-19)? Are you familiar with the role of serum tryptase testing in patients with a suspected anaphylactic reaction? Expert faculty, Dr. Cem Akin, discusses serum tryptase testing and its importance in assessing anaphylaxis in response to COVID-19 vaccination. This moder...
ACHL

What Every Clinician Needs to Know About COVID-19 and Thrombosis

As the COVID-19 pandemic continues to wage on, are you prepared to prevent and treat your patients for COVID-19-related venous thromboembolism (VTE)? In this short vlog, learn how to develop appropriate regimens with antithrombotic therapy for this patient population and hear about the promising PREVENT-HD trial. Leading VTE expert, Dr. Gregory Piazza, outlines key real-world insights that you ...
ACHL

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map